AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17257536 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide (1.0 ml)
Number of subjects: 37
Study 15170529 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory physiotherapy
Number of subjects: 100
Study 15170529 — intervention group
Group type: COMPARATOR
Intervention: Suction
Number of subjects: 100
Study 11666117 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA (tablets, 60 mg, twice daily for 8 weeks)
Number of subjects: 40
Study 11666117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9840297 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA) for detecting serum anti-H. pylori immunoglobulin G antibodies
Number of subjects: 249
Study 7988248 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mediastinal radiation
Number of subjects: 0
Study 7988248 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 0
Study 2928037 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 gm/kg alcohol
Number of subjects: 48
Study 2928037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 2928037 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 gm/kg alcohol
Number of subjects: 48
Study 31784559 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA treatment
Number of subjects: 87
Study 31784559 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 87
Study 28918120 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MMWR), 12-session program
Number of subjects: 0
Study 28918120 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MMWR)
Number of subjects: 0
Study 24603938 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (n=14, 54-60 training sessions)
Number of subjects: 23
Study 24603938 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=9)
Number of subjects: 23
Study 23707162 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuated Listeria monocytogenes vaccine strain with cholera toxin adjuvant
Number of subjects: 8
Study 23707162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 22027793 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 65
Study 22027793 — intervention group
Group type: COMPARATOR
Intervention: 40 mg simvastatin
Number of subjects: 65
Study 20008225 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy as post-remission therapy
Number of subjects: 300000
Study 20008225 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic transplantation
Number of subjects: 300000
Study 20008225 — intervention group
Group type: EXPERIMENTAL
Intervention: New and targeted agents
Number of subjects: 300000
Study 17307760 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent odor (e.g., strawberry/sweet)
Number of subjects: 14
Study 17307760 — intervention group
Group type: COMPARATOR
Intervention: Incongruent odor (e.g., strawberry/sour)
Number of subjects: 14
Study 15568526 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Inflation, Asymmetrical Compression (RIAC) device
Number of subjects: 423
Study 15568526 — intervention group
Group type: COMPARATOR
Intervention: Sequential Circumferential Compression Device (SCD)
Number of subjects: 423
Study 15513239 — intervention group
Group type: EXPERIMENTAL
Intervention: Short lines (1-8 cm)
Number of subjects: 0
Study 15513239 — intervention group
Group type: COMPARATOR
Intervention: Long lines (8-28 cm)
Number of subjects: 0
Study 15513239 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard US legal-sized paper background
Number of subjects: 0
Study 15513239 — intervention group
Group type: COMPARATOR
Intervention: Doubled width background
Number of subjects: 0
Study 10962123 — intervention group
Group type: EXPERIMENTAL
Intervention: Late potentials (LP group)
Number of subjects: 101
Study 10962123 — intervention group
Group type: COMPARATOR
Intervention: NLP group
Number of subjects: 101
Study 10962123 — intervention group
Group type: COMPARATOR
Intervention: NLP patients
Number of subjects: 101
Study 9347373 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratracheal furosemide (0.5 mg/kg)
Number of subjects: 12
Study 8478839 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentoplasty (n = 15)
Number of subjects: 43
Study 8478839 — intervention group
Group type: COMPARATOR
Intervention: Introflexion (n = 18)
Number of subjects: 43
Study 8478839 — intervention group
Group type: COMPARATOR
Intervention: Combination of both (n = 10)
Number of subjects: 43
Study 3748681 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiant warmer
Number of subjects: 13
Study 31754836 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 0
Study 31754836 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 0
Study 29329559 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured process to simplify medication administration using the Medication Regimen Simplification Guide for Residential Aged Care.
Number of subjects: 8
Study 29329559 — intervention group
Group type: COMPARATOR
Intervention: Routine care (comparison group).
Number of subjects: 8
Study 27010092 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 121
Study 27010092 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKA)
Number of subjects: 121
Study 24994546 — intervention group
Group type: EXPERIMENTAL
Intervention: Endeavor zotarolimus-eluting stent (E-ZES) in premarket trials
Number of subjects: 5650
Study 24994546 — intervention group
Group type: COMPARATOR
Intervention: Endeavor zotarolimus-eluting stent (E-ZES) in postmarket trials
Number of subjects: 5650
Study 22284900 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg
Number of subjects: 69
Study 22284900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 21246855 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuina
Number of subjects: 90
Study 21246855 — intervention group
Group type: COMPARATOR
Intervention: Taijiquan
Number of subjects: 90
Study 21246855 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 90
Study 18423314 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium sulfate/ferumoxsil
Number of subjects: 20
Study 18423314 — intervention group
Group type: COMPARATOR
Intervention: Barium sulfate
Number of subjects: 20
Study 15877756 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) added to autologous bone graft
Number of subjects: 30
Study 15877756 — intervention group
Group type: COMPARATOR
Intervention: Non-PRP side (control)
Number of subjects: 30
Study 15877756 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP side
Number of subjects: 30
Study 15877756 — intervention group
Group type: COMPARATOR
Intervention: Non-PRP side
Number of subjects: 30
Study 12944692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum gamma glutamyl transpeptidase (GGTP)
Number of subjects: 25
Study 12944692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lactate dehydrogenase (LDH)
Number of subjects: 25
Study 12944692 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum superoxide dismutase (SOD)
Number of subjects: 25
Study 12944692 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy age-matched individuals)
Number of subjects: 25
Study 10533448 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy after curative resection
Number of subjects: 13
Study 10533448 — intervention group
Group type: COMPARATOR
Intervention: Observation following curative resection
Number of subjects: 13
Study 8740090 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioimmunoassay (RIA) method
Number of subjects: 0
Study 8740090 — intervention group
Group type: COMPARATOR
Intervention: Gas Chromatographic/Mass Spectrometric method (GC/MS)
Number of subjects: 0
Study 15278664 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.1 mg.kg(‐1)
Number of subjects: 20
Study 15278664 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.2 mg.kg(‐1)
Number of subjects: 20
Study 6628500 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 100 mg
Number of subjects: 15
Study 6628500 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 150 mg
Number of subjects: 15
Study 6628500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6628500 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment with optimal therapeutic dose (100-400 mg)
Number of subjects: 15
Study 6628500 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for depressive patients)
Number of subjects: 15
Study 30680643 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) treatment
Number of subjects: 60
Study 30680643 — intervention group
Group type: COMPARATOR
Intervention: Positioning treatment (control)
Number of subjects: 60
Study 27391237 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy (20 weeks of manualized therapy)
Number of subjects: 58
Study 27391237 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Cognitive Behavioral Analysis System of Psychotherapy interventions
Number of subjects: 58
Study 25792351 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anaesthesia (GA)
Number of subjects: 60
Study 25792351 — intervention group
Group type: COMPARATOR
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 60
Study 23402870 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-tocopherol (γT) supplementation
Number of subjects: 13
Study 23402870 — intervention group
Group type: EXPERIMENTAL
Intervention: γ-tocopherol (γT) treatment
Number of subjects: 13
Study 23402870 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunflower oil capsule)
Number of subjects: 13
Study 21165661 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback (n = 8)
Number of subjects: 14
Study 21165661 — intervention group
Group type: COMPARATOR
Intervention: Placebo feedback (n = 6)
Number of subjects: 14
Study 21165661 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback
Number of subjects: 14
Study 21165661 — intervention group
Group type: COMPARATOR
Intervention: Placebo feedback
Number of subjects: 14
Study 21165661 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-neurofeedback and Placebo feedback
Number of subjects: 14
Study 18805066 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARITE artificial disc
Number of subjects: 133
Study 18805066 — intervention group
Group type: COMPARATOR
Intervention: BAK cages and iliac crest autograft
Number of subjects: 133
Study 17277042 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 160
Study 17277042 — intervention group
Group type: COMPARATOR
Intervention: Biphasic human insulin 30 (BHI 30)
Number of subjects: 160
Study 15536455 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan 100 mg
Number of subjects: 37
Study 15536455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 11973185 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 100
Study 11973185 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 100
Study 11973185 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (2.5 microg/kg)
Number of subjects: 100
Study 10387959 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 0
Study 10387959 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 1% cream
Number of subjects: 0
Study 10387959 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 0
Study 8562003 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program promoting condom use among sex workers
Number of subjects: 500
Study 2756914 — intervention group
Group type: EXPERIMENTAL
Intervention: fat‐modified lactoovovegetarian diet (LOV)
Number of subjects: 26
Study 2756914 — intervention group
Group type: EXPERIMENTAL
Intervention: diet with 60% of plant protein replaced with lean meat (LM)
Number of subjects: 26
Study 2756914 — intervention group
Group type: COMPARATOR
Intervention: high‐fat diet
Number of subjects: 26
Study 337176 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 40
Study 337176 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (Dilantin)
Number of subjects: 40
Study 6896301 — intervention group
Group type: EXPERIMENTAL
Intervention: AVC plus tamoxifen (Adriamycin 40 mg/m2 i.v., vincristin 1 mg/m2 i.v. on day 1, cyclophosphamide 200 mg/m2 p.o. on days 3-6, and tamoxifen 20 mg twice daily)
Number of subjects: 84
Study 6896301 — intervention group
Group type: COMPARATOR
Intervention: AVC (Adriamycin 40 mg/m2 i.v., vincristin 1 mg/m2 i.v. on day 1, cyclophosphamide 200 mg/m2 p.o. on days 3-6)
Number of subjects: 84
Study 30587515 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 83749
Study 30587515 — intervention group
Group type: COMPARATOR
Intervention: Non-users of aspirin
Number of subjects: 83749
Study 30587515 — intervention group
Group type: EXPERIMENTAL
Intervention: All stroke risk in women with prior HDP
Number of subjects: 83749
Study 30587515 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke before age 60 in women with prior HDP
Number of subjects: 83749
Study 30185394 — intervention group
Group type: EXPERIMENTAL
Intervention: BZF961 500 mg BID for 3 days
Number of subjects: 0
Study 30185394 — intervention group
Group type: EXPERIMENTAL
Intervention: BZF961 50 mg QD or BID with ritonavir
Number of subjects: 0
Study 30185394 — intervention group
Group type: EXPERIMENTAL
Intervention: BZF961 lower-dose regimens
Number of subjects: 0
Study 30185394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27003145 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-capacity serrated biopsy forceps with jaw diameter 2.4 mm (SER2)
Number of subjects: 136
Study 27003145 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-capacity oval forceps with jaw diameter 2.4 mm (OVL)
Number of subjects: 136
Study 27003145 — intervention group
Group type: COMPARATOR
Intervention: Large-capacity serrated biopsy forceps with jaw diameter 2.2 mm (SER1)
Number of subjects: 136
Study 25286175 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT-S (Culturally Informed Therapy for Schizophrenia), 15 sessions
Number of subjects: 69
Study 25286175 — intervention group
Group type: COMPARATOR
Intervention: PSY-ED (Psychoeducation), 3 sessions
Number of subjects: 69
Study 22818246 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual telephone counseling (n=67)
Number of subjects: 215
Study 22818246 — intervention group
Group type: EXPERIMENTAL
Intervention: Group face‐to‐face counseling (n=74)
Number of subjects: 215
Study 22818246 — intervention group
Group type: COMPARATOR
Intervention: Mail/control group (n=74)
Number of subjects: 215
Study 22818246 — intervention group
Group type: EXPERIMENTAL
Intervention: Face‐to‐face program
Number of subjects: 215
Study 22818246 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone program
Number of subjects: 215
Study 22818246 — intervention group
Group type: COMPARATOR
Intervention: Control program
Number of subjects: 215
Study 20044810 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ursodeoxycholic acid
Number of subjects: 124
Study 16740515 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching methodology with home visits
Number of subjects: 88
Study 16740515 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control group)
Number of subjects: 88
Study 12582105 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndromic management for treating STIs
Number of subjects: 0
Study 12582105 — intervention group
Group type: EXPERIMENTAL
Intervention: Global guidelines for syndromic management
Number of subjects: 0
Study 11202589 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective screening for AAA based on risk factors (current smokers)
Number of subjects: 2755
Study 11202589 — intervention group
Group type: EXPERIMENTAL
Intervention: General screening of half the male population aged 65‐83 years
Number of subjects: 2755
Study 9119416 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickle cell disease (HbSS)
Number of subjects: 2570
Study 9119416 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickle cell gene carriers (HbAS)
Number of subjects: 2570
Study 9119416 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean fetal hemoglobin in sickle cell disease
Number of subjects: 2570
Study 8447522 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine B
Number of subjects: 37
Study 8447522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 3533087 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 300 mg suppositories, rectally, t.i.d., for 10 days
Number of subjects: 45
Study 3533087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 28674135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention consisting of education and advice about the benefits of weight loss and physical activity, and the Australian New South Wales Get Healthy Service.
Number of subjects: 280
Study 28674135 — intervention group
Group type: COMPARATOR
Intervention: Control group (original cohort)
Number of subjects: 280
Study 26496648 — intervention group
Group type: EXPERIMENTAL
Intervention: Paromomycin Intramuscular Injection (PMIM) at 11 mg/kg once daily for 21 days
Number of subjects: 120
Study 26496648 — intervention group
Group type: EXPERIMENTAL
Intervention: Paromomycin Intramuscular Injection (PMIM)
Number of subjects: 120
Study 23392475 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-motion perception training (3,360 practice trials over 12 days in Experiment 1 and 6 days in Experiment 2)
Number of subjects: 11
Study 23392475 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-motion perception training with visual input (Experiment 3)
Number of subjects: 11
Study 21852344 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified 'You Make the Difference' programme over six weekly sessions
Number of subjects: 301
Study 21852344 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 301
Study 20027367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoten (anxiolytic preparation)
Number of subjects: 0
Study 17267634 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct inoculation of standard aerobic and anaerobic blood culture bottles
Number of subjects: 4306
Study 17267634 — intervention group
Group type: COMPARATOR
Intervention: Inoculation after transport in sodium polyanethol sulfonate tubes
Number of subjects: 4306
Study 15021967 — intervention group
Group type: COMPARATOR
Intervention: 0.01% SDS
Number of subjects: 12
Study 15021967 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% SDS
Number of subjects: 12
Study 15021967 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% SDS
Number of subjects: 12
Study 11454075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND) 100 mg/fortnight
Number of subjects: 15
Study 11454075 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 400 mg/day
Number of subjects: 15
Study 11454075 — intervention group
Group type: COMPARATOR
Intervention: Dietary counselling
Number of subjects: 15
Study 9784903 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary rotational atherectomy (PTCRA)
Number of subjects: 14
Study 9784903 — intervention group
Group type: COMPARATOR
Intervention: Plain balloon angioplasty
Number of subjects: 14
Study 7609494 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 0
Study 7609494 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 0
Study 3294619 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymic Humoral Factor (THF)
Number of subjects: 15
Study 3294619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30654826 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurotrauma Evidence Translation (NET) intervention
Number of subjects: 1943
Study 30654826 — intervention group
Group type: COMPARATOR
Intervention: Control condition (access to clinical practice guideline)
Number of subjects: 1943
Study 27351548 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated eccentric exercise (EE) group
Number of subjects: 36
Study 27351548 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise (CG) group
Number of subjects: 36
Study 25646326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low α-tocopherol (<12.0 μmol/L)
Number of subjects: 1605
Study 25646326 — intervention group
Group type: EXPERIMENTAL
Intervention: Low γ-tocopherol (<0.81 μmol/L)
Number of subjects: 1605
Study 23696683 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 131
Study 23696683 — intervention group
Group type: COMPARATOR
Intervention: Control procedure
Number of subjects: 131
Study 21849660 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 842
Study 20439556 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy-rich diet (DR)
Number of subjects: 120
Study 20439556 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diet (ER)
Number of subjects: 120
Study 20439556 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 120
Study 17225981 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 treatment
Number of subjects: 68
Study 17225981 — intervention group
Group type: COMPARATOR
Intervention: Control (surgery without treatment)
Number of subjects: 68
Study 15129930 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (H-CHO)
Number of subjects: 12
Study 15129930 — intervention group
Group type: COMPARATOR
Intervention: Low carbohydrate diet (L-CHO)
Number of subjects: 12
Study 11411657 — intervention group
Group type: EXPERIMENTAL
Intervention: rhuEPO therapy
Number of subjects: 40
Study 11411657 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 9674008 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal-based conjunctival flap
Number of subjects: 81
Study 9674008 — intervention group
Group type: COMPARATOR
Intervention: Fornix-based conjunctival flap
Number of subjects: 81
Study 7985596 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC-18790 (mean dose 5.9 +/- 3.5 mg)
Number of subjects: 12
Study 7985596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12